The analysis of the C-T-M network in Figures 7G, H indicates that FA and fenofibrate, both used in the treatment of hyperlipidemia, have several overlapping targets, including CYP1A2, MMP2, MMP9, and NOS2. Here, NOS2 is linked to hyperlipidemia.